P-096 - ASSESSING THE USE OF NONINVASIVE BIOMARKERS IN DRUG DEVELOPMENT FOR NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH).
X. Tian1, S. Li2, I. Kim2, B. Saluja2, S. Doddapaneni2, C. Sahajwalla2; 1Rutgers University, Piscataway, NJ, USA, 2US Food and Drug Administration, Silver Spring, MD, USA.
.jpg "Xiaofan Tian, N/A photo")
.png)